April 19, 2024

New Research Discovered HIV Variant Can Cause Patients To Develop AIDS Twice As Fast


In a February 7, 2022 article published in Forbes, Mason Bissada reported that British researchers have discovered a new HIV variant[1]https://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2022/february/20220207_hiv-variant that doubles the rate of immune system decline in infected people and can cause AIDS to set in two to three times faster than other strains of the virus.

According to the report, the research[2]https://www.science.org/doi/10.1126/science.abk1688, led by scientists from the University of Oxford’s Big Data Institute, found people living with the newly discovered variant—named subtype-B—have higher HIV viral loads than those living with other variants. The variant was identified in the Netherlands, where researchers believe it has circulated for years.

Also, the report cited that Moderna[3]https://investors.modernatx.com/news/news-details/2022/IAVI-and-Moderna-Launch-Trial-of-HIV-Vaccine-Antigens-Delivered-Through-mRNA-Technology/default.aspx announced in January 2022 that it had begun phase 1 of clinical trials for its HIV vaccine, implementing the same mRNA technology used to create its coronavirus vaccine.

Moreover, on January 4, 2022, the Centers for Disease Control and Prevention reported people with HIV in New York—the state with the highest per-capita rate of HIV—were less likely to be vaccinated against Covid-19 than the general population.  The report also adds that some researchers have speculated that the coronavirus can mutate numerous times in the systems of HIV-positive people due to their compromised immunity, potentially causing novel variants like omicron[4]https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4014499.

Editor’s Note: Based on the summary above, can you see the apparent brewing of the HIV outbreak?  This Forbes article is just one of the dozens already discussing this new HIV sub-variant.

To share a few:

Are we to believe naively that this is merely a coincidence with the announcement that Moderna is already on its Phase 1 of development for an mRNA HIV vaccine?  Are they conditioning societies once again so that an easy authorization for emergency use of their doses could be released?

For those who are not aware, in October 2020, a group of researchers warned that some coronavirus vaccine candidates under development could increase susceptibility to HIV. [See https://nypost.com/2020/10/20/some-covid-19-vaccines-could-increase-hiv-risk-researchers/. Read the study https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32156-5/fulltext.] Also, in December 2020, Australia halted the clinical trials of the COVID-19 vaccine due to false HIV positives [see https://www.thehealthsite.com/news/australia-halts-covid-19-vaccine-development-due-to-false-hiv-positives-785387/].

Last year, The Expose already warned us about what they have discovered from the UK public data: 5% decline of immune system per week among the vaccinated individuals, which equals auto-immune deficiency syndrome [see UK Government Data: Vaccinated are Seeing their Immune Response Plummet by About 5% Each Week].

We also have featured Dr. Nathan Thompson, a Chiropractor, who shared worsening clinical outcomes of his vaccinated patients, plummeting antibodies discovered through HIV test [see the story in Pathologist Reports 20-fold Increase of Cancer Diagnosis Among Vaccinated Patients].

Could the timely discovery of HIV sub-variant be another ploy of “predictive programming?” What happened to Marburg disease? What other diseases do they have in their pipeline to hide the adverse events of covid jabs?  Are we really seeing the vaccine-disease-vaccine scheme here?  This is a sure profit for Big Pharma, isn’t it?

Read Original Article

Read Online

Click the button below if you wish to read the article on the website where it was originally published.

Read Offline

Click the button below if you wish to read the article offline.

Leave a Reply

Your email address will not be published. Required fields are marked *